valproic acid has been researched along with Bone Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anwar, MJ; Radhakrishna, KV; Sharma, A; Vohora, D | 1 |
| Kantor, S; Morris, MJ; O'Brien, TJ; Poulton, IJ; Senn, SM; Sims, NA; Wark, JD | 1 |
2 other study(ies) available for valproic acid and Bone Diseases
| Article | Year |
|---|---|
Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-β3 content in bone of female mice.
Topics: Animals; Anticonvulsants; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases; Estradiol; Female; Mice; Phenytoin; Raloxifene Hydrochloride; Seizures; Selective Estrogen Receptor Modulators; Transforming Growth Factor beta3; Valproic Acid | 2014 |
Adverse effects of valproate on bone: defining a model to investigate the pathophysiology.
Topics: Animals; Bone Density; Bone Diseases; Disease Models, Animal; Female; Genetic Predisposition to Disease; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred CBA; Mice, Inbred DBA; Species Specificity; Tibia; Valproic Acid | 2010 |